لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bakker T; Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Methodology, Amsterdam Public Health, Amsterdam, Netherlands. Electronic address: t.bakker1@amsterdamumc.nl., Klopotowska JE; Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Digital Health, Amsterdam Public Health, Amsterdam, Netherlands., Dongelmans DA; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Quality of Care, Amsterdam Public Health, Amsterdam, Netherlands., Eslami S; Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Vermeijden WJ; Department of Intensive Care, Medisch Spectrum Twente, Enschede, Netherlands., Hendriks S; Department of Intensive Care, Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands., Ten Cate J; Department of Intensive Care, The Netherlands Cancer Institute, Amsterdam, Netherlands., Karakus A; Department of Intensive Care Diakonessenhuis Utrecht, Utrecht, Netherlands., Purmer IM; Department of Intensive Care, Haga Hospital, The Hague, Netherlands., van Bree SHW; Department of Intensive Care, Ziekenhuis Gelderse Vallei, Ede, Netherlands., Spronk PE; Department of Intensive Care Medicine, Gelre Hospitals, Apeldoorn, Netherlands., Hoeksema M; Zaans Medisch Centrum, Department of Anesthesiology, Intensive Care and Pain Management, Zaandam, Netherlands., de Jonge E; Department of Intensive Care, Leiden University Medical Center, Leiden, Netherlands., de Keizer NF; Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Quality of Care, Amsterdam Public Health, Amsterdam, Netherlands., Abu-Hanna A; Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Methodology, Amsterdam Public Health, Amsterdam, Netherlands.

مؤلفون مشاركون: SIMPLIFY study group

المصدر: Lancet (London, England) [Lancet] 2024 Feb 03; Vol. 403 (10425), pp. 439-449. Date of Electronic Publication: 2024 Jan 20.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Critical Care* , Decision Support Systems, Clinical* , Ichthyosiform Erythroderma, Congenital* , Lipid Metabolism, Inborn Errors* , Muscular Diseases*, Humans ; Drug Combinations ; Drug Interactions ; Intensive Care Units ; Adolescent ; Adult

SCR Disease Name: Chanarin-Dorfman Syndrome

المؤلفون: Klopotowska JE; Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health, Amsterdam, The Netherlands., Leopold JH; Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health, Amsterdam, The Netherlands., Bakker T; Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health, Amsterdam, The Netherlands., Yasrebi-de Kom I; Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health, Amsterdam, The Netherlands., Engelaer FM; Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands., de Jonge E; Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands., Haspels-Hogervorst EK; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van den Bergh WM; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Renes MH; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Jong BT; Department of Intensive Care, Isala Hospital, Zwolle, The Netherlands., Kieft H; Department of Intensive Care, Isala Hospital, Zwolle, The Netherlands., Wieringa A; Department of Clinical Pharmacy, Isala Hospital, Zwolle, The Netherlands., Hendriks S; Department of Intensive Care, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Lau C; Department of Hospital Pharmacy, Albert Schweitzer Hospital, Dordrecht, The Netherlands., van Bree SHW; Department of Intensive Care, Hospital Gelderse Vallei, Ede, The Netherlands., Lammers HJW; Department of Hospital Pharmacy, Hospital Gelderse Vallei, Ede, The Netherlands., Wierenga PC; Department of Hospital Pharmacy, Hospital Gelderse Vallei, Ede, The Netherlands., Bosman RJ; Department of Intensive Care Medicine, OLVG Hospital, Amsterdam, The Netherlands., de Jong VM; Department of Intensive Care Medicine, OLVG Hospital, Amsterdam, The Netherlands., Slijkhuis M; Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, The Netherlands., Franssen EJF; Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, The Netherlands., Vermeijden WJ; Department of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands., Masselink J; Department of Hospital Pharmacy, Medisch Spectrum Twente, Enschede, The Netherlands., Purmer IM; Department of Intensive Care, Haga Hospital, The Hague, The Netherlands., Bosma LE; Department of Hospital Pharmacy, Haga Hospital, The Hague, The Netherlands., Hoeksema M; Department of Intensive Care, Zaans Medisch Centrum, Zaandam, The Netherlands., Wesselink E; Department of Hospital Pharmacy, Zaans Medisch Centrum, Zaandam, The Netherlands., de Lange DW; Department of Intensive Care, University Medical Center, University Utrecht, Utrecht, The Netherlands., de Keizer NF; Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health, Amsterdam, The Netherlands., Dongelmans DA; Department of Intensive Care, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, The Netherlands., Abu-Hanna A; Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health, Amsterdam, The Netherlands.

المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jan; Vol. 90 (1), pp. 164-175. Date of Electronic Publication: 2023 Sep 04.

نوع المنشور: Observational Study; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Drug-Related Side Effects and Adverse Reactions*/epidemiology , Drug-Related Side Effects and Adverse Reactions*/etiology , Acute Kidney Injury*/chemically induced , Acute Kidney Injury*/epidemiology, Humans ; Retrospective Studies ; Drug Interactions ; Intensive Care Units

المؤلفون: Ewoldt TMJ; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. t.ewoldt@erasmusmc.nl.; Department Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. t.ewoldt@erasmusmc.nl.; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands. t.ewoldt@erasmusmc.nl., Abdulla A; Department Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Rietdijk WJR; Department Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Muller AE; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Medical Microbiology, Haaglanden Medical Center, The Hague, The Netherlands., de Winter BCM; Department Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Hunfeld NGM; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Purmer IM; Department of Intensive Care Medicine, Haga Hospital, The Hague, The Netherlands., van Vliet P; Department of Intensive Care Medicine, Haaglanden Medical Center, The Hague, The Netherlands., Wils EJ; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Intensive Care Medicine, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands., Haringman J; Department of Intensive Care Medicine, Isala Hospital, Zwolle, The Netherlands., Draisma A; Department of Intensive Care Medicine, Groene Hart Hospital, Gouda, The Netherlands., Rijpstra TA; Department of Intensive Care Medicine, Amphia Hospital, Breda, The Netherlands., Karakus A; Department of Intensive Care Medicine, Diakonessenhuis, Utrecht, The Netherlands., Gommers D; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Endeman H; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Koch BCP; Department Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.

المصدر: Intensive care medicine [Intensive Care Med] 2022 Dec; Vol. 48 (12), pp. 1760-1771. Date of Electronic Publication: 2022 Nov 09.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1238 (Electronic) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE

مواضيع طبية MeSH: Critical Illness*/therapy , beta-Lactams*/therapeutic use, Humans ; Middle Aged ; Ciprofloxacin/therapeutic use ; Intensive Care Units ; Anti-Bacterial Agents/therapeutic use ; Monobactams

المؤلفون: Klanderman RB; Department of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bulle EB; Department of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Heijnen JWM; TRIP Hemovigilance and Biovigilance Office, Leiden, The Netherlands., Allen J; Department of Quality and Security, HagaZiekenhuis, The Hague, The Netherlands., Purmer IM; Department of Intensive Care, HagaZiekenhuis, The Hague, The Netherlands., Kerkhoffs JH; Department of Quality and Security, HagaZiekenhuis, The Hague, The Netherlands., Wiersum-Osselton JC; TRIP Hemovigilance and Biovigilance Office, Leiden, The Netherlands., Vlaar APJ; Department of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

المصدر: Transfusion [Transfusion] 2022 Mar; Vol. 62 (3), pp. 594-599. Date of Electronic Publication: 2022 Feb 17.

نوع المنشور: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE

مواضيع طبية MeSH: Acute Lung Injury*/etiology , Transfusion Reaction*/complications , Transfusion-Related Acute Lung Injury*/complications, Aged ; Antibodies ; Detergents ; Humans ; Male ; Solvents/adverse effects

المؤلفون: Woittiez NJC; Department of Intensive Care, Haga Teaching Hospital, The Hague, The Netherlands., van Prehn J; Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands. Electronic address: j.vanprehn@lumc.nl., van Immerseel F; Livestock Gut Health Team Ghent, Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium., Goossens E; Livestock Gut Health Team Ghent, Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium., Bauer MP; Department of Acute Internal Medicine, Leiden University Medical Centre, Leiden, The Netherlands., Ramspek CL; Department of Surgery, Haga Teaching Hospital, The Hague, The Netherlands., Slangen RME; Department of Gastroenterology and Hepatology, Haga Teaching Hospital, The Hague, The Netherlands., Purmer IM; Department of Intensive Care, Haga Teaching Hospital, The Hague, The Netherlands., Ludikhuize J; Department of Intensive Care, Haga Teaching Hospital, The Hague, The Netherlands; Section of Acute Medicine, Department of Internal Medicine, VU University Medical Center, Vrije Universiteit, Amsterdam, the Netherlands.

المصدر: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 Feb; Vol. 115, pp. 224-228. Date of Electronic Publication: 2021 Dec 17.

نوع المنشور: Case Reports; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Clostridium Infections*/diagnosis , Sepsis*, Base Composition ; Clostridium perfringens/genetics ; Hemolysis ; Humans ; Phylogeny ; RNA, Ribosomal, 16S ; Sequence Analysis, DNA

المؤلفون: Abdulla A; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Ewoldt TMJ; Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands., Purmer IM; Department of Intensive Care, Haga Hospital, The Hague, The Netherlands., Muller AE; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Medical Microbiology, Haaglanden Medical Center, The Hague, The Netherlands., Gommers D; Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands., Endeman H; Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands., Koch BCP; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.

المصدر: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2021 Apr; Vol. 17 (4), pp. 359-368. Date of Electronic Publication: 2021 Feb 02.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7607 (Electronic) Linking ISSN: 17425255 NLM ISO Abbreviation: Expert Opin Drug Metab Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Critical Illness*, Anti-Bacterial Agents/*administration & dosage , beta-Lactams/*administration & dosage, Age Factors ; Anti-Bacterial Agents/pharmacokinetics ; Dose-Response Relationship, Drug ; Drug Monitoring ; Female ; Humans ; Male ; Precision Medicine ; Sex Factors ; beta-Lactams/pharmacokinetics

المؤلفون: Bakker T; Amsterdam UMC (location AMC), Department of Medical Informatics, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: t.bakker1@amsterdamumc.nl., Abu-Hanna A; Amsterdam UMC (location AMC), Department of Medical Informatics, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: a.abu-hanna@amsterdamumc.nl., Dongelmans DA; Amsterdam UMC (location AMC), Department of Intensive Care Medicine, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: d.a.dongelmans@amsterdamumc.nl., Vermeijden WJ; Department of Intensive Care, Medisch Spectrum Twente, Koningsplein 1, 7512, KZ, Enschede, the Netherlands. Electronic address: j.vermeijden@mst.nl., Bosman RJ; Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Oosterpark 9, 1091, AC, Amsterdam, the Netherlands. Electronic address: r.j.bosman@olvg.nl., de Lange DW; Department of Intensive Care and Dutch Poison Information Center, University Medical Center Utrecht, University Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands. Electronic address: d.w.delange@umcutrecht.nl., Klopotowska JE; Amsterdam UMC (location AMC), Department of Medical Informatics, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: j.e.klopotowska@amsterdamumc.nl., de Keizer NF; Amsterdam UMC (location AMC), Department of Medical Informatics, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: n.f.keizer@amsterdamumc.nl., Hendriks S; Department of Intensive Care, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands., Ten Cate J; Department of Intensive Care, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schutte PF; Department of Intensive Care, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Balen D; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Duyvendak M; Department of Hospital Pharmacy, Antonius Hospital, Sneek, The Netherlands., Karakus A; Department of Intensive Care Diakonessenhuis Utrecht, Utrecht, The Netherlands., Sigtermans M; Department of Intensive Care Diakonessenhuis Utrecht, Utrecht, The Netherlands., Kuck EM; Department of Hospital Pharmacy, Diakonessenhuis Utrecht, Utrecht, The Netherlands., Hunfeld NGM; Department of Intensive Care, Erasmus MC, Rotterdam, The Netherlands; Department of Hospital Pharmacy, ErasmusMC, Rotterdam, The Netherlands., van der Sijs H; Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., de Feiter PW; Department of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Wils EJ; Department of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Spronk PE; Department of Intensive Care Medicine, Gelre Hospitals, Apeldoorn, The Netherlands., van Kan HJM; Department of Clinical Pharmacy, Gelre Hospitals, Apeldoorn, The Netherlands., van der Steen MS; Department of Intensive Care, Ziekenhuis Gelderse Vallei, Ede, The Netherlands., Purmer IM; Department of Intensive Care, Haga Hospital, The Hague, The Netherlands., Bosma BE; Department of Hospital Pharmacy, Haga Hospital, The Hague, The Netherlands., Kieft H; Department of Intensive Care, Isala Hospital, Zwolle, The Netherlands., van Marum RJ; Department of Clinical Pharmacology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands; Amsterdam UMC (location VUmc), Department of Elderly Care Medicine, Amsterdam, The Netherlands., de Jonge E; Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands., Beishuizen A; Department of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands., Movig K; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, The Netherlands., Mulder F; Department of Pharmacology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Franssen EJF; OLVG Hospital, Department of Clinical Pharmacy, Amsterdam, The Netherlands., van den Bergh WM; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bult W; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hoeksema M; Zaans Medisch Centrum, Department of Anesthesiology, Intensive Care and Painmanagement, Zaandam, The Netherlands., Wesselink E; Department of Clinical Pharmacy, Zaans Medisch Centrum, Zaandam, The Netherlands.

مؤلفون مشاركون: SIMPLIFY study group

المصدر: Journal of critical care [J Crit Care] 2021 Apr; Vol. 62, pp. 124-130. Date of Electronic Publication: 2020 Dec 01.

نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8610642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8615 (Electronic) Linking ISSN: 08839441 NLM ISO Abbreviation: J Crit Care Subsets: MEDLINE

مواضيع طبية MeSH: Critical Care* , Pharmaceutical Preparations*, Drug Interactions ; Humans ; Intensive Care Units ; Retrospective Studies

المؤلفون: Algera AG; Department of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands., Pisani L; Department of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands., Serpa Neto A; Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Victoria, Australia.; Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital and University of Melbourne, Melbourne, Victoria, Australia., den Boer SS; Department of Intensive Care, Spaarne Gasthuis, Haarlem and Hoofddorp, the Netherlands., Bosch FFH; Department of Intensive Care, Rijnstate Hospital, Arnhem, the Netherlands., Bruin K; Department of Intensive Care, Westfriesgasthuis, Hoorn, the Netherlands., Klooster PM; Department of Intensive Care, Haaglanden MC, the Hague, the Netherlands., Van der Meer NJM; Department of Intensive Care, Amphia Hospital, Breda, the Netherlands., Nowitzky RO; Department of Intensive Care, Haga Hospital, the Hague, the Netherlands., Purmer IM; Department of Intensive Care, Haga Hospital, the Hague, the Netherlands., Slabbekoorn M; Department of Intensive Care, Haaglanden MC, the Hague, the Netherlands., Spronk PE; Department of Intensive Care, Gelre Hospitals, Apeldoorn, the Netherlands., van Vliet J; Department of Intensive Care, Rijnstate Hospital, Arnhem, the Netherlands., Weenink JJ; Department of Intensive Care, Spaarne Gasthuis, Haarlem and Hoofddorp, the Netherlands., Gama de Abreu M; Department of Anesthesiology and Intensive Care, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Dresden, Germany., Pelosi P; Department of Surgical Sciences and Integrated Diagnostics, San Martino Policlinico Hospital, IRCCS for Oncology, University of Genoa, Genoa, Italy., Schultz MJ; Department of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands.; Nuffield Department of Medicine, Oxford University, Oxford, England.; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand., Paulus F; Department of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands.; ACHIEVE Centre of Expertise, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands.

مؤلفون مشاركون: Writing Committee and Steering Committee for the RELAx Collaborative Group

المصدر: JAMA [JAMA] 2020 Dec 22; Vol. 324 (24), pp. 2509-2520.

نوع المنشور: Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Positive-Pressure Respiration/*methods , Respiratory Insufficiency/*therapy, APACHE ; Aged ; Critical Illness ; Female ; Humans ; Intensive Care Units ; Kaplan-Meier Estimate ; Length of Stay ; Male ; Middle Aged ; Oxygen/blood ; Pneumonia, Ventilator-Associated ; Pneumothorax/etiology ; Positive-Pressure Respiration/adverse effects ; Ventilator Weaning

المؤلفون: Leegwater E; Apotheek Haagse Ziekenhuizen, The Hague, The Netherlands.; Department of Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands., Kraaijenbrink BVC; Amsterdam University Medical Centers - location VUmc, Amsterdam, The Netherlands., Moes DJAR; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Purmer IM; Department of Intensive Care, Haga Teaching Hospital, The Hague, The Netherlands., Wilms EB; Apotheek Haagse Ziekenhuizen, The Hague, The Netherlands.; Department of Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands.

المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2020 Jun 01; Vol. 75 (6), pp. 1554-1558.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Ceftriaxone* , Critical Illness*, Anti-Bacterial Agents/therapeutic use ; Humans ; Microbial Sensitivity Tests ; Monte Carlo Method